report adj ep vs consensu top
end compani guidanc beat came us tax reform
also got benefit plant sale asia top-
line growth remain strong volum ex plant sale better price
make stock under-perform receiv number question
earn print result stock weak friday vs
like culprit confus around chines plant sale adjust result
ebitda benefit ep investor strip gain tax reform
benefit earn right down-the-middl guidanc howev mani investor
posit fundament beat given improv end-market trend currenc
guid outlook full year fiscal guidanc rais vs
prior guid mostli due us tax reform benefit
plant sale benefit continu believ guidanc conserv given
includ anticip benefit luan deal size accret
annual anticip close futur acquisit addit compani
remain highli activ project/asset bid process invest
capac balanc sheet improv fundament increas backlog
project signific dri powder capit deploy still like stori
view today dip technic bump fundament chang
adjust ep estim exclud anticip
benefit luan deal keep estim compar apd guid pt
goe ep deploy cash vs
previou pt base ep deploy cash
estim also exclud potenti capit deploy opportun
quarterli annual ep usd
consensu number thomson reuter
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
rais usd
return equiti ttm
link barclay live interact chart
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
overweight believ product well
posit benefit continu global growth
adopt gase continu organ volum
price growth along new project
product effort expect drive earn
growth valuat vs peer keep us
upsid case base upon effect
deploy capit could add
accret would make upsid case
repres upsid ep
downsid case base upon
bear case ep
duffi fischer herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
author contribut research report research analyst unless otherwis indic
public date top report reflect local time report produc may differ releas date provid
gmt
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
procedur pleas
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis barclay research depart
oper independ absa research depart absa research produc absa bank limit act corpor
invest bank divis part barclay africa group limit affili invest bank barclay bank plc elig
client may receiv research report research depart may reach differ conclus may contain differ
conflict forecast recommend trade idea
materi conflict barclay bank and/or affili provid invest bank servic product chemic inc nyse
relat announc tax free pro-rata spin
price sourc thomson reuter last avail close price relev trade market unless anoth time sourc
